MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Hyperspectral Imaging Supports Brain Neurosurgery

By MedImaging International staff writers
Posted on 19 Nov 2018
Print article
Image: Hyperspectral image of the brain; the tumor is indicated by red pixels (Photo courtesy of HELICoiD project).
Image: Hyperspectral image of the brain; the tumor is indicated by red pixels (Photo courtesy of HELICoiD project).
A new research project is adapting hyperspectral imaging (HSI) to discriminate between healthy and malignant tissues in the brain during surgical procedures.

Researchers at the University of Las Palmas de Gran Canaria (ULPGC; Spain), Imperial College London (ICL; United Kingdom), Universidad Politécnica de Madrid (UPM; Spain), and other institutions participating in the HypErspectraL Imaging Cancer Detection (HELICoiD) project are exploiting HSI to develop a device capable of real-time delineation of cancerous tumor tissue from normal brain tissue during neurosurgical operations, allowing surgeons to minimize the margin of healthy tissue needs to avert potential metastasis.

The prototype device is composed of two hyperspectral cameras covering a spectral range of 400–1,700 nm. A hardware accelerator is used to speed up the hyperspectral brain cancer detection algorithm to achieve processing during the time of surgery, which was developed using a labeled dataset comprised of more than 300,000 spectral signatures. In a preliminary study, thematic maps of seven hyperspectral images of in vivo brain tissue captured and processed during neurosurgical operations demonstrated that the system is able to discriminate normal from tumor tissue in the brain within one minute.

To achieve this real-time discrimination, huge amounts of information captured by the sensors is processed using a K-Nearest Neighbors (KNN) filtering algorithm, which is optimized and parallelized by exploiting using graphical processing unit (GPU) technology for real-time processing during brain cancer surgical procedures. The parallel version of the KNN filtering algorithm can effectively handle the extremely high computational requirements needed to evaluate different classes simultaneously. The study describing the HIS development process was published in the July 2018 issue of Sensors.

“They, being the neurosurgeons, had a problem and we had a technology. But every patient’s tumor and brain produce a unique spectral fingerprint, and so the first algorithms to make usable images took a half hour; now the total time is around six seconds,” said study co-author Professor Gustavo Marrero Callicó, PhD, of ULPGC. “Now they are equipped to provide neurosurgeons with a tool to operate on the slimmest of margins in real-time. The next goal is refining the database to make it general enough to detect cancers in many situations.”

HSI can help acquire large numbers of spectral bands throughout the electromagnetic spectrum (both within and beyond the visual range) with a very fine spatial resolution. So fine, in fact, that for every image pixel a full spectrum of color can be detected. Using this information and complex classification algorithms, it is possible to determine which material or substance is located in each pixel.

Related Links:
University of Las Palmas de Gran Canaria
Imperial College London
Universidad Politécnica de Madrid


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Mobile Digital C-arm X-Ray System
HHMC-200D

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more